CN114028463A - Moistening cream for relieving various gynecological diseases - Google Patents
Moistening cream for relieving various gynecological diseases Download PDFInfo
- Publication number
- CN114028463A CN114028463A CN202111238009.2A CN202111238009A CN114028463A CN 114028463 A CN114028463 A CN 114028463A CN 202111238009 A CN202111238009 A CN 202111238009A CN 114028463 A CN114028463 A CN 114028463A
- Authority
- CN
- China
- Prior art keywords
- phase
- extract
- stearate
- gynecological diseases
- various gynecological
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 201000010099 disease Diseases 0.000 title claims abstract description 34
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 34
- 239000006071 cream Substances 0.000 title claims abstract description 23
- 239000000284 extract Substances 0.000 claims abstract description 39
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 36
- 235000011187 glycerol Nutrition 0.000 claims abstract description 14
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims abstract description 14
- 230000003020 moisturizing effect Effects 0.000 claims abstract description 14
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 claims abstract description 14
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims abstract description 12
- 210000000582 semen Anatomy 0.000 claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229920001202 Inulin Polymers 0.000 claims abstract description 10
- CNRDTAOOANTPCG-UHFFFAOYSA-N dodecyl carbamate Chemical compound CCCCCCCCCCCCOC(N)=O CNRDTAOOANTPCG-UHFFFAOYSA-N 0.000 claims abstract description 10
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 10
- 229940029339 inulin Drugs 0.000 claims abstract description 10
- 229940100460 peg-100 stearate Drugs 0.000 claims abstract description 10
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 claims abstract description 8
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 8
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 claims abstract description 8
- 229940015975 1,2-hexanediol Drugs 0.000 claims abstract description 8
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 8
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000004166 Lanolin Substances 0.000 claims abstract description 8
- 239000004264 Petrolatum Substances 0.000 claims abstract description 8
- 241001165494 Rhodiola Species 0.000 claims abstract description 8
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 claims abstract description 8
- 235000021355 Stearic acid Nutrition 0.000 claims abstract description 8
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 claims abstract description 8
- 229940036350 bisabolol Drugs 0.000 claims abstract description 8
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229940082500 cetostearyl alcohol Drugs 0.000 claims abstract description 8
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229940039717 lanolin Drugs 0.000 claims abstract description 8
- 235000019388 lanolin Nutrition 0.000 claims abstract description 8
- 239000002480 mineral oil Substances 0.000 claims abstract description 8
- 235000010446 mineral oil Nutrition 0.000 claims abstract description 8
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims abstract description 8
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims abstract description 8
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229940066842 petrolatum Drugs 0.000 claims abstract description 8
- 235000019271 petrolatum Nutrition 0.000 claims abstract description 8
- 229960005323 phenoxyethanol Drugs 0.000 claims abstract description 8
- 229960003415 propylparaben Drugs 0.000 claims abstract description 8
- 229950011392 sorbitan stearate Drugs 0.000 claims abstract description 8
- 239000008117 stearic acid Substances 0.000 claims abstract description 8
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 claims abstract description 8
- 241000096284 Gynochthodes officinalis Species 0.000 claims abstract description 7
- 229920001214 Polysorbate 60 Polymers 0.000 claims abstract description 6
- 229940075529 glyceryl stearate Drugs 0.000 claims abstract description 6
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims abstract description 6
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims abstract description 6
- 229960002216 methylparaben Drugs 0.000 claims abstract description 6
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 claims abstract description 6
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 claims abstract description 6
- 229940113124 polysorbate 60 Drugs 0.000 claims abstract description 6
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 claims abstract description 6
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 claims abstract description 6
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 5
- 241000005787 Cistanche Species 0.000 claims abstract description 5
- 229940116229 borneol Drugs 0.000 claims abstract description 5
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 5
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 5
- 238000003756 stirring Methods 0.000 claims description 12
- 239000002994 raw material Substances 0.000 claims description 9
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims description 7
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims description 7
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 6
- 239000003995 emulsifying agent Substances 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 4
- 230000001804 emulsifying effect Effects 0.000 claims description 4
- 239000003921 oil Substances 0.000 claims description 4
- 238000005086 pumping Methods 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 3
- 238000007599 discharging Methods 0.000 claims description 2
- 238000000265 homogenisation Methods 0.000 claims description 2
- 238000004806 packaging method and process Methods 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 238000004321 preservation Methods 0.000 claims description 2
- 229940082941 sedum roseum root extract Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 9
- 201000008100 Vaginitis Diseases 0.000 abstract description 5
- 206010047791 Vulvovaginal dryness Diseases 0.000 abstract description 4
- 208000006374 Uterine Cervicitis Diseases 0.000 abstract description 3
- 206010008323 cervicitis Diseases 0.000 abstract description 3
- 206010046914 Vaginal infection Diseases 0.000 abstract description 2
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 abstract 1
- 210000001672 ovary Anatomy 0.000 description 42
- 239000002674 ointment Substances 0.000 description 29
- 210000001015 abdomen Anatomy 0.000 description 22
- 230000003203 everyday effect Effects 0.000 description 15
- 230000004054 inflammatory process Effects 0.000 description 12
- 206010061218 Inflammation Diseases 0.000 description 11
- 239000003814 drug Substances 0.000 description 9
- 208000037093 Menstruation Disturbances Diseases 0.000 description 8
- 206010027339 Menstruation irregular Diseases 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 210000004291 uterus Anatomy 0.000 description 8
- 210000001215 vagina Anatomy 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 230000001568 sexual effect Effects 0.000 description 6
- 208000003251 Pruritus Diseases 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 230000005906 menstruation Effects 0.000 description 5
- 230000028327 secretion Effects 0.000 description 5
- 210000003756 cervix mucus Anatomy 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 238000000554 physical therapy Methods 0.000 description 4
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 208000000509 infertility Diseases 0.000 description 3
- 230000036512 infertility Effects 0.000 description 3
- 231100000535 infertility Toxicity 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 208000025661 ovarian cyst Diseases 0.000 description 3
- 230000035935 pregnancy Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 208000021663 Female sexual arousal disease Diseases 0.000 description 2
- 206010021703 Indifference Diseases 0.000 description 2
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 2
- 208000006262 Psychological Sexual Dysfunctions Diseases 0.000 description 2
- 206010049677 Salpingo-oophoritis Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 206010046798 Uterine leiomyoma Diseases 0.000 description 2
- 238000001467 acupuncture Methods 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 210000004996 female reproductive system Anatomy 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000002611 ovarian Effects 0.000 description 2
- 230000016087 ovulation Effects 0.000 description 2
- 239000011505 plaster Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010000242 Abortion threatened Diseases 0.000 description 1
- 208000005641 Adenomyosis Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010003693 Atrophic vulvovaginitis Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 206010008254 Cervical cyst Diseases 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 241000336291 Cistanche deserticola Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- RRAFCDWBNXTKKO-UHFFFAOYSA-N Eugenol Natural products COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 1
- 208000026351 Fallopian Tube disease Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 208000029578 Muscle disease Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010033425 Pain in extremity Diseases 0.000 description 1
- 208000037062 Polyps Diseases 0.000 description 1
- 208000002500 Primary Ovarian Insufficiency Diseases 0.000 description 1
- 208000008350 Pruritus Vulvae Diseases 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 208000005985 Threatened Abortion Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000016599 Uterine disease Diseases 0.000 description 1
- 208000032159 Vaginal inflammation Diseases 0.000 description 1
- 206010051873 Vaginal relaxation Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000037237 body shape Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 201000003505 cervical polyp Diseases 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000004246 corpus luteum Anatomy 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 201000009274 endometriosis of uterus Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- -1 eugenol glycoside Chemical class 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 210000003016 hypothalamus Anatomy 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 208000015124 ovarian disease Diseases 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 201000010808 postmenopausal atrophic vaginitis Diseases 0.000 description 1
- 206010036601 premature menopause Diseases 0.000 description 1
- 208000017942 premature ovarian failure 1 Diseases 0.000 description 1
- 239000000583 progesterone congener Substances 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000035946 sexual desire Effects 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 208000013464 vaginal disease Diseases 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- 208000015317 vulvar disease Diseases 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/746—Morinda
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/43—Cuscutaceae (Dodder family), e.g. Cuscuta epithymum or greater dodder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/64—Orobanchaceae (Broom-rape family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pregnancy & Childbirth (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to a moistening cream for relieving various gynecological diseases, which comprises water, mineral oil, glycerin I, petrolatum, cetostearyl alcohol, lanolin, sorbitan stearate, polysorbate-60, PEG-100 stearate, glyceryl stearate, rhodiola root extract, semen cuscutae extract, inulin lauryl carbamate, stearic acid, morinda officinalis extract, cistanche extract, borneol, 1, 2-hexanediol, phenoxyethanol, hydrogenated lecithin, EDTA disodium, methylparaben, propylparaben and bisabolol; the moisturizing cream for relieving various gynecological diseases can relieve various gynecological diseases such as cervicitis, vaginal dryness, vaginitis and the like, and obtains unexpected technical effects.
Description
Technical Field
The invention belongs to the field of emulsifiers, and particularly relates to a moistening cream for relieving various gynecological diseases.
Background
The gynecological diseases are diseases of female reproductive system, including vulvar diseases, vaginal diseases, uterine diseases, fallopian tube diseases, ovarian diseases, etc. according to different disease positions. Due to the increased living pressure of modern women and the lack of exercise and health care, the health degree of many people is not good, and various gynecological diseases are often entangled. Meanwhile, because of privacy, a large number of women have no good meaning to see a doctor and treat even if the women know the disease, and the disease condition is often worsened.
In addition, as gynecological diseases are concurrent with the female reproductive system, on one hand, various gynecological diseases can bring great pain and make a sense of doubt to patients; on the other hand, normal couple life is affected, and the next generation is affected. Although the medical knowledge of modern people is continuously increased with the continuous development of modern medical technology, the affected parts of gynecological diseases are many, and the conditions of the patients are often complicated, such as cervicitis, irregular menstruation, vaginal dryness, cold womb, dysmenorrhea, ovarian cyst and the like, so that the conditions of the patients are often repeated and recurred, thereby seriously affecting the normal life of the patients and reducing the life quality of the patients.
Although western medicines or traditional Chinese medicine treatment can obviously improve or cure various gynecological diseases, the medicines often have certain toxicity, and the treatment process often costs a lot. Meanwhile, a certain degree of privacy disclosure is inevitably caused in the medical treatment process. Besides the disease treatment in hospitals, the traditional Chinese medicine physical therapy methods such as massage, beauty treatment and health care can also have certain relieving and even treating effects on gynecological diseases. Particularly, the method of combining certain plaster, acupuncture, moxibustion and the like can greatly relieve the pain and the lingering of the patient under the condition of fully ensuring the privacy of the patient. However, the existing plaster for traditional Chinese medicine physiotherapy usually has single function, and the main function is convenient for physiotherapy operations such as massage, acupuncture and moxibustion and the like. In addition, some ointments have poor applicability and certain side effects.
Disclosure of Invention
The invention aims to provide a moistening ointment for relieving various gynecological diseases, which can solve the problems of single function, certain side effect and poor applicability of the existing ointment for traditional Chinese medicine physiotherapy.
In order to achieve the purpose, on one hand, the invention relates to the technical scheme that: a moistening cream for relieving various gynecological diseases is characterized in that: comprises water, mineral oil, glycerin I, petrolatum, cetostearyl alcohol, lanolin, sorbitan stearate, polysorbate-60, PEG-100 stearate, glyceryl stearate, rhodiola root extract, semen Cuscutae extract, inulin lauryl carbamate, stearic acid, Morinda officinalis extract, Cistanchis herba extract, Borneolum Syntheticum, 1, 2-hexanediol, phenoxyethanol, hydrogenated lecithin, disodium EDTA, methylparaben, propylparaben, and bisabolol.
Preferably, the following ingredients are in parts by weight: 55.57% of water, 10% of mineral oil, 7% of glycerol, 6% of petrolatum, 3.5% of cetostearyl alcohol, 2% of lanolin, 2% of sorbitan stearate, 2% of polysorbate-602%, 1% of PEG-100 stearate, 1% of glycerol stearate, 0.9% of rhodiola root extract, 0.9% of semen cuscutae extract, 0.45% of inulin lauryl carbamate, 1.35% of glycerol II, 1.5% of stearic acid, 1.2% of morinda officinalis extract, 1.2% of cistanche extract, 0.8% of borneol, 0.5% of 1, 2-hexanediol, 0.5% of phenoxyethanol, 0.3% of hydrogenated lecithin, 0.1% of disodium EDTA, 0.1% of methylparaben, 0.05% of propylparaben and 0.08% of bisabolol.
Preferably, the moistening cream comprises 22 raw materials, wherein PEG-100 stearate and glycerol stearate form an emulsifier raw material, and the rhodiola root extract and the semen cuscutae extract form a skin conditioner raw material, and the rhodiola root extract has the effects of preventing tumors, enhancing the immune function, delaying senility, resisting fatigue, anoxia, preventing radiation, bidirectionally regulating central nerves, repairing and protecting organisms and the like; the semen cuscutae extract has the effects of nourishing liver and kidney, preventing miscarriage, improving eyesight and stopping diarrhea. Can be used for treating sexual impotence, spermatorrhea, enuresis, frequent micturition, soreness of knee joint, blurred vision, tinnitus, fetal leakage due to kidney deficiency, threatened abortion, and spleen and kidney deficiency; externally treating vitiligo; inulin lauryl carbamate and glycerol II constitute an emulsifier material.
Preferably, the contained 22 raw materials of the moisturizing cream are divided into four main groups which are respectively named as an A phase, a B phase, a C phase and a D phase, wherein the A phase comprises glycerin I, petrolatum, cetostearyl alcohol, lanolin, sorbitan stearate, polysorbate-60, PEG-100 stearate and glyceryl stearate, cistanche extracts, borneol, phenoxyethanol and hydrogenated lecithin; wherein phase B comprises water, mineral oil, stearic acid and radix Morindae officinalis extract; wherein the phase C comprises inulin lauryl carbamate, glycerol II and 1, 2-hexanediol; wherein the phase D comprises radix Rhodiolae extract, semen Cuscutae extract, disodium EDTA, methyl hydroxybenzoate, propyl hydroxybenzoate, and bisabolol.
On the other hand, the invention also provides a preparation method of the moisturizing cream for relieving various gynecological diseases, which comprises the following steps:
s1: adding water into an emulsifying pot, stirring, adding phase B, stirring, heating to 80-85 deg.C, stirring for 20min, and keeping the temperature for use;
s2: sequentially adding the phase A into an oil phase pot, heating to 80-85 deg.C, dissolving completely, and keeping the temperature for use;
s3: pumping the material body of the oil phase pot prepared in the step S2 into the emulsifying pot prepared in the step S1, starting medium-high speed homogenization for 5-8min after pumping, and stirring for 30min under heat preservation;
s4: cooling to 55 deg.C, adding phase C with pH value adjusted, and stirring well, wherein phase C pH value is controlled between 6.0-6.5;
s5: cooling to 45 ℃, sequentially adding the phase D, and uniformly stirring;
s6: and (6) detecting whether the finished product in the S5 is qualified, and discharging to wait for packaging if the finished product is qualified.
The invention has the advantages and beneficial effects that: the moisturizing cream provided by the invention is prepared from Chinese herbal medicines given by nature, and a traditional Chinese medicine emulsifiable paste refined by a traditional extraction and emulsification process, and is used for relieving various gynecological diseases.
Detailed Description
The embodiments in the present description are described in a progressive manner, each embodiment focuses on differences from other embodiments, and the same and similar parts among the embodiments are referred to each other.
The invention relates to a moistening cream for relieving various gynecological diseases, which has the technical key points that: comprises water, mineral oil, glycerin I, petrolatum, cetostearyl alcohol, lanolin, sorbitan stearate, polysorbate-60, PEG-100 stearate, glyceryl stearate, rhodiola root extract, semen Cuscutae extract, inulin lauryl carbamate, stearic acid, Morinda officinalis extract, Cistanchis herba extract, Borneolum Syntheticum, 1, 2-hexanediol, phenoxyethanol, hydrogenated lecithin, disodium EDTA, methylparaben, propylparaben, and bisabolol.
The Morinda officinalis extract has the effects of warming kidney yang, improving sexual function and strengthening tendons and bones.
The cistanche deserticola extract has the following health care functions for women: the immunity can be enhanced, and the contained nutrient components can play a certain role in the proliferation of lymphocyte and enhance the humoral immunity; secondly, the skin-care product can effectively resist aging, has a certain protection effect on the skin and delays aging; loosening bowel to relieve constipation, improving enterokinesia, and inhibiting water absorption of large intestine; finally, the compound can be used for treating infertility, and the contained eugenol glycoside can enhance the hormone secretion of hypothalamus pituitary ovary and enhance the function of corpus luteum.
The moisturizing cream protected by the invention has the following four main conditioning effects: firstly, private parts can be purified, the Shenque point and the Guanyuan point can be continuously smeared for 3-7 days, the vagina is moist, internal reproduction can be nourished, garbage and toxin which cannot be reserved can be metabolized every day, the internal reproduction environment is purified, and the antiviral capacity is improved; the composition can be moistened and helped, is smeared twice a day, is moist like the ovulation period every day, is helpful for pleasure and satisfaction of the house, is sensitive in advance, improves the gripping feeling, and greatly improves the quality of life of the couple; the uterus can be warmed for regulating menstruation again, 1 holiday period is continuously wiped, so that the blood stasis of the uterus body is metabolized, the internal environment of the uterus is improved, and the pregnancy capability and quality are improved; finally, the product has the effects of body beautification and body shaping, and after the product is continuously applied for one month, the skin of the whole body begins to be compact and smooth due to the improvement and balance of more than 20 hormone levels such as estrogen, progestogen and the like; the vulva and the chest begin to become fuller and firmer; the waist becomes tangible. After long-term application, the body shape is kept, and the skin is compact, smooth and elastic.
The moistening cream protected by the invention has the functions of tonifying kidney, replenishing vital essence, invigorating spleen and nourishing blood; mainly regulates the gynecological diseases such as irregular menstruation, vaginal atrophy and dryness, low ovulation rate, sexual life disturbance, vaginitis, infertility and the like caused by premature ovarian failure.
Typical cases are: non-viable cells
1. Li Shi, Liaoning Panjin, is 45 years old in the present year. The initial diagnosis of 3 and 5 months in 2021 shows that the menstruation is irregular for 6 years, the menstruation volume is very little, the time is only 3 days, and the color is brown. The traditional Chinese medicine is taken every year for conditioning, the vital energy and blood are seriously deficient, the face is pale, the whole face is brownish, the ovary repairing paste is applied to the navel and the lower abdomen triangle area for 2 times every day, and the face is continuously applied for a week, so that the face complexion is improved; after one month of use, the second menstruation appeared bright red, the dosage was more than before, and the leucorrhea had no abnormal flavor.
2. Zhang somewhere, Shenyang in Liaoning, 52 years old. 18 days of 2021, 18 days of first diagnosis, chief complaints, cervicitis and repeated outbreaks, after the child is born, the sexual indifference starts, no couple lives, the ovary repairing paste is smeared on the navel and the lower abdomen triangle area for 2-3 times every day, after two months of continuous use, the inflammation is eliminated, the sexual intercourse of the couple is obviously improved, and the affection of the couple is recovered.
3. Somewhere in charge, Jinzhou Liaoning, 35 years old. When a child is 3 years old, the woman has gynecological inflammation and accompanying sexual indifference after self-delivery, and does not have the desire of sexual intercourse, the ovary repairing ointment is smeared on the navel and the lower abdomen triangle area for 2-3 times every day, the disease is greatly improved after the ovary repairing ointment is continuously used for 25 days, the inflammation is eliminated, the private part is moist, the couple life is not resisted any more, and the sexual intercourse can be performed normally.
4. Li Shi, 23 years old, Liaoning Dalian, with great stress, causes endocrine disturbance type obesity, irregular menstruation, which is clean after 20 days, and also has cervicitis and often soreness of waist. The ovary repairing paste is smeared on the navel eye and the lower abdomen triangle area for 2-3 times every day, and is continuously smeared for half a month, so that bean curd residue-shaped substances flow for several days. The waist is not sour, and the menstruation can come according to the month now.
5. Zhangzhi, 43 years old, Liaoning Dong hong Kong people often have soreness and pain in waist and legs, gynecological inflammation for 10 years, and repeated taking of medicine, and the patients who have drunk traditional Chinese medicine can not be cured all the time. The ovary repairing paste is smeared on the navel eye and the lower abdomen triangle area 2 times a day and on the third day, the waist soreness is changed well; after one month of continuous use, the gynecological inflammation disappears, and simultaneously the symptoms of waist soreness and leg pain disappear.
6. Anzhi, 39 years old, Shenyang Liaoning who was infertility in marriage for 6 years, and who had no possibility of pregnancy after seeking medical care everywhere. By introduction, couples use the ovarian repairing paste to daub the navel eye and the lower abdomen trigone for 2-3 times every day for 50 days, and the couple is pregnant after checking.
7. Zhangqi, 25 years old, Liaoning Fuxin, long-term irregular menstruation, cold uterus, severe dysmenorrhea, dry vagina accompanied with frigidity, and glandular muscle disease through examination. The ovary repairing ointment is applied to the navel eye and the lower abdomen triangle area for 2-3 times every day, after one month of continuous application, a plurality of black blood clots are discharged, and the color of the second time of menstruation returns to normal bright red. In addition, the face color is obviously ruddy, meanwhile, the vagina is very moist, and the quality of the couple is greatly improved.
8. Liaozhi Panjin people, 38 years old, have serious deficiency of qi and blood due to long-term sleep deficiency during work, and have extremely small amount of cervical polyp during each menstrual period. The ovary repairing ointment is smeared on bellybutton and lower triangular area 2-3 times a day, after the ovary repairing ointment is continuously smeared for one month, the sleep quality is greatly improved, and the period, the amount and the color of the example fake period are obviously improved.
9. Somebody on the south of the Dong, age 29, pacifying people in Liaoning, and many vaginal secretions, HPV is positive through hospital examination, and the HPV does not improve for three months after the medicine is taken. The ovary repairing ointment is applied to the navel and the lower abdomen triangle area 2-3 times a day, and the ovary repairing ointment is completely recovered to be normal after being continuously applied for 3 months.
10. Yan in 41 years old, Tianjin people have been operated with ovarian cyst but the secretion is excessive. The ovary repairing ointment is applied to the navel eye and the lower abdomen triangle area 2-3 times a day, and obvious improvement is achieved after the ovary repairing ointment is continuously applied for three days.
11. In the case of a person of 33 years old, Beijing, the patient has pelvic effusion and adnexitis for years, the disease is repeated and does not improve all the time, the navel eye and the lower abdomen triangle area are coated with the ovary repairing paste 2-3 times every day, after one month of continuous coating, a plurality of fishy liquid flows for 3 days, the waist is not acid and swollen, and the adnexitis does not relapse.
12. In a certain plum, 35 years old, Shijiazhuang people have a cold sex and a dry and astringent vagina, and are unwilling to carry out normal couple life, so that the old and the wife are in a foreign chance; the ovary repairing paste is smeared on the navel eye and the lower abdomen triangle area for 2-3 times every day, after 8 days of continuous smearing, the vagina is obviously moistened, the gripping force is enhanced, and the sexual desire is better satisfied.
13. Anji, 28 years old, Nei Mongolia red peak, increased the weight to 175 jin half a year after birth, while irregular menstruation, dark and spotty face. The ovary repairing paste is smeared on the navel eye and the lower abdomen triangle area for 2-3 times every day, the improvement is realized after the ovary repairing paste is continuously used for smearing for one treatment course, and the skin color of the face is obviously improved. At the same time, menstruation returns to normal.
14. Zhang somewhere, 36 years old, saddle mountain people in Liaoning province, caused by serious deficiency of qi and blood, irregular menstruation, cold uterus and severe dysmenorrhea. The ovary repairing ointment is applied to the navel and the lower triangular area 2-3 times a day, and after the ovary repairing ointment is continuously applied for one month, the symptoms are obviously improved.
15. If a certain love is 34 years old and people in Haicheng Liaoning have too much leucorrhea, the ovary repairing paste is smeared on the navel eye and the lower abdomen triangle area for 2-3 times every day, and the symptom disappears after the ovary repairing paste is continuously smeared for nearly 25 days.
16. Dongqi, 32 years old, Liaoning Panjin people, suffered from hysteromyoma, 0.9cm x 1.8cm, controlled for 8 years, applying the ovarian repair paste to navel and lower abdomen triangle, 2-3 times per day, continuously applying the product for three months, heating uterus, and examining by hospital that hysteromyoma disappears.
17. Zhou Zhi, 32 years old, Heishan in Liaoning province, suffered from vaginitis and cervicitis, and had no color development after conditioning. The ovary repairing paste is applied to the navel and the lower triangular area 2-3 times per day, a lot of bean curd residue-shaped substances are distributed, and inflammation is obviously relieved.
18. Li in certain 28 years old, Jinzhou people in Liaoning province, suffered from irregular menstruation, appeared brown in color of menstruation and had scanty menstruation. The ovary repairing ointment is applied to navel eyes and the triangular area of lower abdomen 2-3 times a day, the product is continuously applied for more than 20 days, a plurality of black brown blood clots are discharged, the irregular menstruation is obviously relieved, and the color is a little red blood.
19. One in Zhang, 41 years old, Liaoning pacifies people, and the reason for work is often staying up all night, which causes endocrine dyscrasia and gynecological inflammation. The ovary repairing ointment is applied to the navel and the lower triangular area 2-3 times a day, the disease symptoms such as gynecological inflammation and the like are obviously improved after the ovary repairing ointment is continuously applied for one month.
20. A certain Liu, which is 51 years old, Liaoning Panjin people, has ovarian cyst, pelvic effusion, waist soreness, pale complexion and anemia. The ovary repairing ointment is applied to the navel and the lower triangular area 2-3 times a day, two parts of the ovary repairing ointment are continuously applied, and various symptoms are basically eliminated.
21. Hanli, 27 years old, Liaoning Panjin people, married two years never become pregnant. The ovary repairing ointment is smeared on the navel and the lower abdomen trigone for 2-3 times every day, and the pregnancy can be realized unconsciously after the ovary repairing ointment is smeared for one and a half of a day.
22. Somebody, 32 years old, Liaoning crinis people, after production, have loose vagina, inflammation, leakage of urine, and meanwhile, have frigidity and no libido. The ovary repairing ointment is applied to the navel eye and the lower abdomen triangle area 2-3 times a day, and after the ovary repairing ointment is continuously applied for one month, the symptoms of vaginal relaxation, inflammation and urine leakage are obviously improved.
23. Zhangzhi, 52 years old, Shenyang in Liaoning province, suffered from senile vaginitis, and the disease was not cured all the time after repeated cycles. The ovary repairing ointment is applied to the navel and the lower triangular area 2-3 times a day, and the ovary repairing ointment obviously improves after being continuously applied for half a month.
24. A certain Liu is in 47 years old, and people in Jilin Changbai mountain have vagina inflammation, severe pruritus, excessive secretion and second-degree cervical erosion. The ovary repairing ointment is applied to navel eyes and the triangular area of lower abdomen 2-3 times a day for more than 30 days, inflammation is obviously improved through hospital examination, and pruritus is obviously relieved.
25. Some of the ju, 53 years old, in Jinzhou Liaoning people, have cyst polyp, inflammation caused by cold uterus, and excessive vaginal secretion, and the diseases occur repeatedly. The ovary repairing paste is smeared on the navel eye and the lower abdomen trigone for 2-3 times every day, and after the ovary repairing paste is continuously smeared for two months, the vagina inflammation and the uterus cold symptoms are obviously improved.
26. Huang-somewhat, 48 years old, Sichuan adults with gynecological inflammation, cervical cyst reception, excessive secretion and irregular menstruation. The ovary repairing paste is smeared on the navel eye and the lower abdomen trigone for 2-3 times every day, and the product is continuously smeared for one month and then is improved.
27. Huizhi, 38 years old, Liaoning Panjin people suffer from abundant vaginal secretion accompanied by pruritus vulvae and vaginal dryness. The ovary repairing paste is smeared on the navel eye and the lower abdomen triangle area for 2-3 times every day, after the ovary repairing paste is continuously smeared for one month, the symptoms of excessive secretion, pruritus, namely vaginal dryness and the like are obviously relieved, and the vagina is obviously compact and moist when a couple lives.
28. Luzhi, 35 years old, Liaoning Panjin people, suffered from adenomyosis for many years, were bedridden every time and could not go to work, and had not been cured by medical treatment for many years. The ovary repairing ointment is applied to navel eyes and the triangular area of lower abdomen 2-3 times a day, and the menstruation is recovered after the ovary repairing ointment is continuously applied for one month.
29. Certain Yan, 28 years old, Liaoning Panjin people have abnormal vaginal secretion accompanied with pruritus, and the pruritus symptom is obviously relieved after the ovary repairing paste is smeared on the navel and the lower abdomen triangle area for 2-3 times every day and the ovary repairing paste is continuously smeared once.
30. In 28 years old, Liaoning Panjin people have serious qi and blood deficiency and irregular menstruation for three months due to high working pressure, and have no good conditioning effect after drinking traditional Chinese medicines. The ovary repairing ointment is applied to navel eyes and the triangular area of lower abdomen 2-3 times a day, and after being continuously applied for one month, the menstruation comes and the color is bright red.
Although the present invention has been described with reference to the preferred embodiments, it should be understood that various changes and modifications can be made therein by those skilled in the art without departing from the spirit and scope of the invention as defined in the appended claims.
The previous description of the disclosed embodiments is provided to enable any person skilled in the art to make or use the present invention. Various modifications to these embodiments will be readily apparent to those skilled in the art, and the generic principles defined herein may be applied to other embodiments without departing from the spirit or scope of the invention. Thus, the present invention is not intended to be limited to the embodiments shown herein but is to be accorded the widest scope consistent with the principles and novel features disclosed herein.
Claims (5)
1. A moistening cream for relieving various gynecological diseases is characterized in that: comprises water, mineral oil, glycerin I, petrolatum, cetostearyl alcohol, lanolin, sorbitan stearate, polysorbate-60, PEG-100 stearate, glyceryl stearate, rhodiola root extract, semen Cuscutae extract, inulin lauryl carbamate, stearic acid, Morinda officinalis extract, Cistanchis herba extract, Borneolum Syntheticum, 1, 2-hexanediol, phenoxyethanol, hydrogenated lecithin, disodium EDTA, methylparaben, propylparaben, and bisabolol.
2. The moisturizing cream for relieving various gynecological diseases according to claim 1, wherein the moisturizing cream comprises: the following components in parts by weight: 55.57% of water, 10% of mineral oil, 7% of glycerol, 6% of petrolatum, 3.5% of cetostearyl alcohol, 2% of lanolin, 2% of sorbitan stearate, 2% of polysorbate-602%, 1% of PEG-100 stearate, 1% of glycerol stearate, 0.9% of rhodiola root extract, 0.9% of semen cuscutae extract, 0.45% of inulin lauryl carbamate, 1.35% of glycerol II, 1.5% of stearic acid, 1.2% of morinda officinalis extract, 1.2% of cistanche extract, 0.8% of borneol, 0.5% of 1, 2-hexanediol, 0.5% of phenoxyethanol, 0.3% of hydrogenated lecithin, 0.1% of disodium EDTA, 0.1% of methylparaben, 0.05% of propylparaben and 0.08% of bisabolol.
3. The moisturizing cream for relieving various gynecological diseases according to claim 1, wherein the moisturizing cream comprises: the moisturizing and skin-moistening cream comprises 22 raw materials, wherein PEG-100 stearate and glycerol stearate form an emulsifier raw material, wherein rhodiola rosea root extract and semen cuscutae extract form a skin conditioner raw material, and inulin lauryl carbamate and glycerol II form an emulsifier raw material.
4. The moisturizing cream for relieving various gynecological diseases according to claim 1, wherein the moisturizing cream comprises: the 22 raw materials of the moisturizing cream are divided into four main groups which are respectively named as an A phase, a B phase, a C phase and a D phase, wherein the A phase comprises glycerin I, petrolatum, cetostearyl alcohol, lanolin, sorbitan stearate, polysorbate-60, PEG-100 stearate and glyceryl stearate, cistanche extracts, borneol, phenoxyethanol and hydrogenated lecithin; wherein phase B comprises water, mineral oil, stearic acid and radix Morindae officinalis extract; wherein the phase C comprises inulin lauryl carbamate, glycerol II and 1, 2-hexanediol; wherein the phase D comprises radix Rhodiolae extract, semen Cuscutae extract, disodium EDTA, methyl hydroxybenzoate, propyl hydroxybenzoate, and bisabolol.
5. A method for preparing moisturizing cream for relieving various gynecological diseases as claimed in claims 1 to 4, which is characterized in that: the preparation method comprises the following steps:
s1: adding water into an emulsifying pot, stirring, adding phase B, stirring, heating to 80-85 deg.C, stirring for 20min, and keeping the temperature for use;
s2: sequentially adding the phase A into an oil phase pot, heating to 80-85 deg.C, dissolving completely, and keeping the temperature for use;
s3: pumping the material body of the oil phase pot prepared in the step S2 into the emulsifying pot prepared in the step S1, starting medium-high speed homogenization for 5-8min after pumping, and stirring for 30min under heat preservation;
s4: cooling to 55 deg.C, adding phase C with pH value adjusted, and stirring well, wherein phase C pH value is controlled between 6.0-6.5;
s5: cooling to 45 ℃, sequentially adding the phase D, and uniformly stirring;
s6: and (6) detecting whether the finished product in the S5 is qualified, and discharging to wait for packaging if the finished product is qualified.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111238009.2A CN114028463A (en) | 2021-10-25 | 2021-10-25 | Moistening cream for relieving various gynecological diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111238009.2A CN114028463A (en) | 2021-10-25 | 2021-10-25 | Moistening cream for relieving various gynecological diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114028463A true CN114028463A (en) | 2022-02-11 |
Family
ID=80141802
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111238009.2A Pending CN114028463A (en) | 2021-10-25 | 2021-10-25 | Moistening cream for relieving various gynecological diseases |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114028463A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103070781A (en) * | 2011-10-26 | 2013-05-01 | 上海家化联合股份有限公司 | Composite emulsifier and emulsion containing the composite emulsifier |
CN106729624A (en) * | 2016-12-30 | 2017-05-31 | 广州绿人生物科技有限公司 | Adjust endocrine anti-aging biological agent, preparation method and applications |
CN108743478A (en) * | 2018-07-11 | 2018-11-06 | 赣州龙九科技有限公司 | A kind of external application adjusts the equilibrium cream and preparation method thereof for skin of releiving |
-
2021
- 2021-10-25 CN CN202111238009.2A patent/CN114028463A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103070781A (en) * | 2011-10-26 | 2013-05-01 | 上海家化联合股份有限公司 | Composite emulsifier and emulsion containing the composite emulsifier |
CN106729624A (en) * | 2016-12-30 | 2017-05-31 | 广州绿人生物科技有限公司 | Adjust endocrine anti-aging biological agent, preparation method and applications |
CN108743478A (en) * | 2018-07-11 | 2018-11-06 | 赣州龙九科技有限公司 | A kind of external application adjusts the equilibrium cream and preparation method thereof for skin of releiving |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103055242B (en) | Chinese herba preparation for improving body quality, reinforcing kidney and raising fetus | |
CN101700288B (en) | Medicine patch for treating infertility caused by cold uterus and preparation method thereof | |
CN103223152A (en) | Medicine for treating infertility caused by uterus coldness | |
CN100569259C (en) | Chinese medicine that treatment is suffered from a deficiency of the kidney and preparation method thereof | |
CN105816617A (en) | Traditional Chinese medicine composition for treating obesity type polycystic ovarian syndrome | |
CN101428106B (en) | Medicament composition for treating female infertility, and uses thereof | |
CN105031331B (en) | A kind of navel patch and preparation method thereof for treating dysmenorrhea | |
CN104055933A (en) | Cornu cervi kidney warming and sperm replenishing soup | |
CN106236859A (en) | Traditional Chinese medicinal hot compress bag formula | |
CN113499405B (en) | Traditional Chinese medicine composition for treating secondary amenorrhea | |
CN114028463A (en) | Moistening cream for relieving various gynecological diseases | |
CN100579568C (en) | Oral Chinese-medicinal composition for treating difficult menstruation | |
CN104042760A (en) | Kidney-tonifying and essence-strengthening soup | |
CN103536848B (en) | The Chinese medicine decoction for the treatment of chronic prostatitis | |
CN103142890B (en) | Traditional Chinese medicine composition for treating phlegm-damp internal resistance type irregular menstruation | |
CN100586471C (en) | Medicine protecting pad for treating hyperplasia of mammary glands | |
CN104547733A (en) | Traditional Chinese medicine for reducing leucorrhea | |
CN101152345B (en) | Traditional Chinese medicine preparation for treating female acyesis caused by ovulation obstacle | |
CN117860861B (en) | Acupoint plaster for promoting follicular development, and preparation method and application thereof | |
CN104173982B (en) | Medicine for treating pelvic inflammation and preparation method | |
CN101653572B (en) | Traditional Chinese medicine coloclysis composition for effectively treating pelvic inflammatory disease | |
CN1290541C (en) | Medicinal extract for tonifying kidney and enriching blood made from foetal fuzz, and its prepn. method | |
CN106266846A (en) | A kind of for decoction medicine treating menoxenia and preparation method thereof | |
CN104056019A (en) | Diuresis promoting and toxicity removing decoction | |
CN105381387B (en) | A kind of drug and preparation method thereof for treating cystitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220211 |